Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-22

Clinical Trial Update: Relaxin Therapy for Atrial Fibrillation [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update describes Phase 1/2 testing of relaxin therapy for atrial fibrillation and related cardiovascular conditions, with the study currently n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Relaxin (Relaxin)

Snippet

Sponsor: Deeptankar DeMazumder | Conditions: Atrial Fibrillation (AF), Arrhythmia | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING